Skip to main content

Table 2 Distribution of the MRSA isolates on the basis of the molecular epidemiological characterization and pattern of resistance to non β-lactam antibiotics

From: Polyclonal non multiresistant methicillin resistant Staphylococcus aureus isolates from clinical cases of infection occurring in Palermo, Italy, during a one-year surveillance period

No. of isolates STa SCCmec type No. of isolates Resistance profileb MLVFctype
46 22 IVa 10 TET 004
2 CLR TET 004
2 CIP 004
1 CIP TET 004
1 GM TET 004
6 susceptible 004
1 CIP SXT 009
1 CIP CLR ERY 017
1 CIP CLR ERY 019
1 susceptible 024
1 susceptible 043
1 CIP CLR ERY 058
1 CIP 059
1 SXT TET 060
1 CIP ERY 061
1 CIP 068
1 TET 070
IVb 7 CIP CLR ERY 023
5 CIP CLR ERY 073
1 CIP CLR ERY SXT 073
13 8 IVc 2 CIP CLR ERY 006
2 CIP 044
2 CIP CLR ERY 044
1 CIP ERY 012
1 CIP GM RIF 018
1 CIP ERY 035
1 CIP CLR ERY GM 045
1 CIP 064
IVa 1 susceptible 003
1 CIP CLR ERY 045
8 1 IVa 3 CLR ERY TET 065
2 CLR ERY TET 033
1 CLR ERY 010
1 CLR ERY 040
1 CLR TET 049
3 50 IVa 2 susceptible 030
1 susceptible 002
3 398 IVa 1 CLR GM RIF TET 029
1 CIP TET 029
1 GM RIF TET 029
2 1517 IVa 2 CLR 057
  1. a ST, sequence type.
  2. b other than β-lactams.
  3. CLR, clarithromycin; CIP, ciprofloxacin; ERY, erythromycin; GM, gentamicin; RIF, rifampicin; SXT, sulfamethoxazole- trimethoprim; TET, tetracycline.
  4. c MLVF, Multiple-Locus Variable-Number Tandem Repeat Fingerprinting.